NO CALL ON RECORD
the engine publishes a call only when every gate clears
SEE THE LEDGER →FINNENCE ▪ THE ASSET FILE
PERMANENT ASSET RECORD · TRACKED BY FINNENCE
IBB
iShares Biotech ETF
$210.81
LAST CLOSE2026-09-22 · +1.8%iShares Biotech ETF — 40 stories tracked over the last 30 days. No call on record.
LAST $210.81·Δ1D +1.8%·Δ20D -0.8%·60D RANGE $185.90–$216.95·FROM 60D HIGH -2.8%·THEMES 1
SECTION 01 · THE MACHINE'S FILE
WHAT FINNENCE THINKS.
NO OPEN PAPER POSITION
the $1K paper fund holds nothing here
VIEW THE PAPER FUND →THEME CONTEXT
Biotech
EMERGINGMEMBER · SCORE 0.622
RS20 -0.023536
NO ABNORMAL MOVES FLAGGED IN THE LAST 45 DAYS
the scanner re-runs hourly; flags land on the radar
ON THE RADAR →SECTION 02 · THE PRICE RECORD
NINETY SESSIONS, ONE LINE.
LAST$210.81Δ1D+1.8%Δ20D-0.8%60D RANGE$185.90–$216.95
INTERACTIVE PRICE — TRADINGVIEW
INTERACTIVE CHART — LOADS WHEN VISIBLE
SECTION 03 · THE STORY FLOW
WHAT THE FEED SAW.
Recent stories2026-09-22 07:14 UTCNEWSUNCLEARIambic maintains momentum from string of Big Pharma partnerships by aiming for IPO - Fierce Biotech
2026-09-21 18:24 UTCNEWSUNCLEARSEC-FDA Information-Sharing MOU: Implications for Pharma and Biotech - Morgan Lewis
2026-09-21 14:32 UTCNEWSUNCLEARDrugmaker Adarx Pharma Seeks to Raise $371.9 Million in US IPO - Bloomberg.com
2026-09-21 13:19 UTCNEWSBULLISHTelix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A - biospace.com
2026-09-21 12:50 UTCNEWSUNCLEARADRX IPO News - siRNA biotech ADARx Pharmaceuticals sets terms for $350 million IPO - renaissancecapital.com
2026-09-21 11:40 UTCNEWSBEARISHElectra raises $350m in IPO as shares slip on Nasdaq debut - The Pharma Letter
2026-09-21 10:42 UTCNEWSUNCLEARADARx Pharmaceuticals targets $1.74 billion valuation in US IPO - Reuters
2026-09-21 10:34 UTCNEWSUNCLEARRNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Bradenton Herald
2026-09-21 08:29 UTCNEWSMIXEDRetension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede - Fierce Biotech
2026-09-21 08:29 UTCNEWSBULLISHRetension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede - fiercebiotech.com
2026-09-21 04:45 UTCNEWSUNCLEARHBM Healthcare Investments Announces IPO of Portfolio Company Electra Therapeutics - TradingView
2026-09-21 04:20 UTCNEWSBULLISHChinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
2026-09-20 21:11 UTCNEWSUNCLEARElectra Therapeutics Prices $350 Million In Upsized IPO To Advance Precision Medicines For Immune Diseases And Cancer - Pulse 2.0
2026-09-18 22:39 UTCNEWSMIXEDRetension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues - WTVB
2026-09-18 21:59 UTCNEWSUNCLEARRTSN IPO News - Hypertension drug developer Retension Pharmaceuticals files for a $58 million IPO - renaissancecapital.com
SECTION 04 · CATALYSTS
NO CATALYSTS ON THE CALENDAR.
LATEST PRICES
2026-09-22 00:00 UTCyfinance$208.73 +0.0%
2026-09-21 00:00 UTCyfinance$205.66 +0.0%
2026-09-18 00:00 UTCyfinance$206.32 -0.0%
2026-09-17 00:00 UTCyfinance$206.20 +0.0%
2026-09-16 00:00 UTCyfinance$203.44 +0.0%
2026-09-15 00:00 UTCyfinance$201.51 -0.0%
2026-09-14 00:00 UTCyfinance$203.97 +0.0%
2026-09-11 00:00 UTCyfinance$202.93 +0.0%
METHODOLOGY · PAPER ONLY
OPEN THE MACHINE →A permanent, data-backed asset record. Calls are immutable; market data and machine detections update. PAPER ONLY · NOT FINANCIAL ADVICE.
INSPECT THE PAPER FUND →